PsyBio continues to develop psycho-targeted, biosynthesized tryptamines and with this authorization becomes the first biotechnology company to obtain government sanctioned, formal, written ...

SAN DIEGO--(BUSINESS WIRE)--CB Therapeutics Inc., the leading synthetic biology company focused on the development and biosynthetic production of existing and novel tryptamines and cannabinoids, is ...

Scientists have engineered a tobacco relative to produce five psychedelic tryptamines, compounds normally scattered across fungi, plants, and animals, in a single crop. The work, published in Science ...

Please provide your email address to receive an email when new articles are posted on . Lifetime classic psychedelic use, particularly tryptamines, may be linked to lower odds for hypertension in the ...

The University College London (UCL) is conducting a new research project called “Understanding Neuroplasticity Induced by Tryptamines (UNITy)” aimed at assessing brain changes and neuroplasticity ...

In fact, researchers are investigating the hallucinogenic drugs' ability to treat other substance abuse disorders. In 2004, a team of pharmacologists at the University of Michigan Medical School, led ...

This article was originally published on Microdose and appears here with permission. The stigma against psychedelics might appear to be fading, with psychedelic startups attracting billions of dollars ...